PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Jun-2022 Lynred launches two multispectral linear array infrared detectors for future Earth observation mission applications Andrew Lloyd Associates
07-Jun-2022 ImmunOs Therapeutics Raises $74 Million Series B Financing Round ImmunOs Therapeutics
06-Jun-2022 CD Formulation Offers Forced Degradation Studies CD Formulation
02-Jun-2022 Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies Boehringer Ingelheim / A*STAR
02-Jun-2022 MedExecWomen Third Annual Conference in Boston, June 14, 2022 SCORR Marketing
02-Jun-2022 Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory Strategy for China and US Novotech Health Holdings Pte Ltd
02-Jun-2022 Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022 BOC Sciences
02-Jun-2022 A New Phase of BOC Sciences Partnership Expansion Unlocked after TIDES USA 2022 BOC Sciences
02-Jun-2022 BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development  BOC Sciences
02-Jun-2022 Complete Virtual Screening Solutions at BOC Sciences to Unleash Novel Drug Discovery Potential BOC Sciences
02-Jun-2022 BOC Sciences Unveils Access to Comprehensive Set of PROTAC In Vitro Evaluation Services BOC Sciences
02-Jun-2022 BOC Sciences: A Robust Isotope Labeling Service Vendor BOC Sciences
01-Jun-2022 JYSELECA®▼ (filgotinib) recommended by NICE for use in patients with Ulcerative Colitis (UC) Galapagos Biotech LTD
01-Jun-2022 AlzeCure’s abstract on pain project TrkA-NAM accepted for presentation at IASP 2022 AlzeCure Pharma AB
01-Jun-2022 JYSELECA®▼ (filgotinib) recommended by NICE for use in patients with Ulcerative Colitis (UC) Galapagos Biotech LTD
31-May-2022 Clasado Biosciences has poster accepted at ISAPP 2022 Clasado Biosciences
31-May-2022 Priothera Receives Fast Track Designation for mocravimod in Combination with Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Post Remission Therapy of Acute Myeloid Leukemia (AML) Patients Priothera
31-May-2022 Minoryx raises EUR 51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy Minoryx Therapeutics
31-May-2022 Registration is now open for Biosensors for Medical Wearables Conference 2022 SAE Media Group
31-May-2022 Global 3D cell culture & 3D bioprinting market is projected to grow at a CAGR of 18.2% By 2032 Visiongain